DRW Securities’s Genocea Biosciences, Inc. GNCA Stock Holding History

DRW Securities’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-59,265	Closed	-$123K	–	405
2019 Q4	$123K	Hold	59,265	–	–	﹤0.01%	218
2019 Q3	$172K	Buy	59,265 +29,265	+98%	+$99.9K	0.01%	127
2019 Q2	$118K	Buy	+30,000	New	+$156K	0.01%	111
2019 Q1	–	Sell	-100,114	Closed	-$230K	–	119
2018 Q4	$230K	Buy	100,114 +41,446	+71%	+$206K	0.01%	54
2018 Q3	$366K	Buy	58,668 +28,668	+96%	+$151K	0.02%	33
2018 Q2	$205K	Buy	+30,000	New	+$224K	0.01%	69

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

DRW Securities's GNCA Position: Q1 2020 in Review

DRW Securities sold out of Genocea Biosciences, Inc. (GNCA) in Q1 2020, closing a stake of 59,265 shares — an estimated $123K sold.

DRW Securities first reported a position in GNCA in Q2 2018 and held it in 6 quarters. The position peaked at $366K in Q3 2018. 33 funds tracked by Wall St. Rank hold GNCA as of Q1 2020.

DRW Securities reported no remaining Genocea Biosciences, Inc. position as of Q1 2020 after selling out during the quarter.
DRW Securities sold 59,265 Genocea Biosciences, Inc. shares in Q1 2020, an estimated $123K.
DRW Securities first reported a position in Genocea Biosciences, Inc. in Q2 2018 and held it in 6 quarters.
DRW Securities's Genocea Biosciences, Inc. position peaked at $366K in Q3 2018.
33 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q1 2020.

Based on DRW Securities's 13F filing for Q1 2020, filed 13 May 2020.